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Abstract
Objectives: Chronic pain is often experienced alongside other long-term conditions (LTCs), yet our understanding of
this, particularly in relation to multimorbidity (2 LTCs) is poor. We aimed to examine associations between the
presence/extent of chronic pain with type/number of LTCs experienced.
Methods: We examined the relationship between number/type of LTCs (N ¼ 45) in UK Biobank participants (n ¼
500,295) who self-reported chronic pain lasting 3 months in seven body sites or widespread. Relative risk ratios (RRR)
for presence/extent of chronic pain sites were compared using logistic regression adjusted for sociodemographic (sex/
age/socioeconomic status) and lifestyle factors (smoking/alcohol intake/BMI/physical activity).
Results: 218,648 participants self-reported chronic pain. Of these, 69.1% reported 1 LTC and 36.2% reported 2
LTCs. In 31/45 LTCs examined, >50% of participants experienced chronic pain. Chronic pain was common with migraine/
headache and irritable bowel syndrome where pain is a primary symptom, but also with mental health conditions and
diseases of the digestive system. Participants with >4 LTCs were over three times as likely to have chronic pain (RRR 3.56,
95% confidence intervals (CIs) 3.44–3.68) and 20 times as likely to have widespread chronic pain (RRR 20.13, 95% CI
18.26–22.19) as those with no LTCs.
Conclusions: Chronic pain is extremely common across a wide range of LTCs. People with multimorbidity were at
higher risk of having a greater extent of chronic pain. These results show that chronic pain is a key factor for consideration
in the management of patients with LTCs or multimorbidity.
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Introduction
Chronic pain, defined as pain lasting for 3 months or more,
is a common and limiting condition worldwide.1–3 Chronic
pain may be experienced in relation to a specific body site,
e.g. low back pain, or be present in multiple sites of the
body, including widespread pain, defined as pain in at least
four of five body sites across three quadrants of the body
and the spine.4 A recent systematic review and meta-
analysis reported that approximately 43% of adults in the
UK live with chronic pain, and between 11% and 17%
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report disabling widespread pain.5 Chronic pain is fre-
quently experienced alongside other long-term conditions
(LTCs).6
Multimorbidity is defined as the presence of two or
more LTCs.7 Treatment plans for patients with multimor-
bidity are often complex and can be challenging, often
resulting in an increased treatment burden due to the work-
load of self-management,8 increased hospital admissions9
and increased potential for polypharmacy,10 and lower
quality of life.11 Despite this, current treatment and clinical
guidelines largely focus on the management of individual
LTCs.
While there is some literature to show that chronic pain
and LTCs often co-exist,12,13 there is much less information
about which LTCs are most often associated with chronic
pain and of the relationship of multimorbidity with chronic
pain. Some recent studies have investigated the effect of
chronic pain in the presence of specific individual LTCs,
for example in major depression and bipolar disorder,14
cardiovascular disease,15 and rheumatoid arthritis.16 How-
ever, studies examining prevalence of comorbidities in
those with chronic pain have generally involved small sam-
ple sizes17 or have only reported on the prevalence of
chronic pain as a comorbidity across a limited range of
conditions17 and we know insufficient information about
chronic pain in the context of multimorbidity or as a comor-
bidity to a wider range of LTCs. This matters because
chronic pain is often poorly managed and can result in
major functional limitations and reduced quality of life
(QoL), which may exacerbate or be exacerbated by the
presence of other LTCs.18
The aim of this study was to examine the association
between both the presence and extent (number of sites) of
chronic pain and the type and number of LTCs experienced
in a large cohort of middle-older aged adults. We hypothe-
sised that those with a greater number of LTCs would be
more likely to have chronic pain and to have more exten-
sive chronic pain.
Methods
Study design and participants
We examined baseline self-reported health from UK Bio-
bank assessment centre visits recorded between 2006
and 2010. This dataset contains information on
502,503 participants who attended recruitment centres
in Scotland, England and Wales to complete
self-administered touch screen and nurse-guided ques-
tionnaires. The data collected covered a range of socio-
demographic, lifestyle and self-reported LTC questions.
This study was covered by the generic ethics approval
for UK Biobank studies from the NHS National
Research Ethics Service (16/NW/0274) and conducted
as part of UK Biobank project 14151.
Classification of chronic pain and LTCs
Participants were asked about pain in the touchscreen ques-
tionnaire; they were first asked if they had any pain in the
last month that interfered with their usual activities in the
following body sites: head, face, neck/shoulder, back,
abdomen, hip, knee or ‘pain all over the body’ (referred
to in this study as widespread pain). Participants who
answered affirmatively to pain in any of these sites were
then asked whether this pain had lasted for 3 months or
longer. Participants answering yes to any of these sites were
considered to have chronic pain. Using this information, a
categorical variable of number of chronic pain sites was
created with the following categories: 0, 1, 2–3, 4 or
‘widespread pain’; used to ascertain the extent of pain
reported.
Self-report LTC information was generated from
responses to a nurse-led questionnaire. Participants
answered whether they had been told by a doctor that they
had a serious illness or disability, and if so, what they were.
Of these, 45 individual self-reported LTCs were chosen for
inclusion in this study based on an adaptation of N ¼ 43
conditions used in previous UK Biobank studies of multi-
morbidity.14,19 Supplementary Table 1 lists all LTCs
examined.
LTCs were examined both as prevalence of individual
LTCs experienced alongside chronic pain, and as the extent
of multimorbidity, by counting LTCs and categorising into:
0, 1, 2–3 or 4 LTCs.
Covariates
Age was categorised into groups: 37–49, 50–59, 60–72
years old. Socioeconomic status was measured using
Townsend score, a measure of UK deprivation,20 and cate-
gorised into quintiles ranging from 1 (least deprived) to 5
(most deprived). Smoking status was categorised into
never-smokers and current/previous smokers. Alcohol
intake was categorised by frequency of intake (Never or
special occasions only, 1–3 times per month, or at least
once per week). BMI was categorised into groups (<18.5,
18.5–24.9, 25–29.9, 30–34.9, 35–39.9 and 40 kg/m2)
based on measurements taken during the baseline assess-
ment then categorised based on WHO obesity guidelines.21
Physical activity was categorised into ‘none’, ‘low’,
‘medium’ and ‘high’ based on the responses to the UK
Biobank physical activity questionnaire.
Statistical analysis
Descriptive analysis was used to examine demographic and
lifestyle factors associated with the presence (yes to one of
more sites of chronic pain) and number of chronic pain sites
(extent of chronic pain). We used cross-tabulations of num-
ber of chronic pain sites by age, gender, socioeconomic
deprivation (Townsend score), smoking status, frequency
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of alcohol consumption, BMI, and physical activity. We
used a 2 test to determine whether there was a significant
difference between pain groups. To measure the relative
risk of the presence and extent of chronic pain in relation
to multimorbidity count, we used a multinomial logistic
regression model controlling for demographic and life-
style variables as described above. Results were consid-
ered significant if p < 0.01. Participants who did not
answer questions on chronic pain were excluded from
analysis (N ¼ 2190; 0.44%). All analysis was conducted
using R version 3.2.3.
Results
A total of N ¼ 500,295 participants provided complete
information on chronic pain and were included in this anal-
ysis. Participants were aged between 37 and 73 (mean age
was 56.53 (standard deviation (SD) ¼ 8.09)); 45.6% (N ¼
228,069) of participants were male.
Demographic and lifestyle factors
Table 1 shows demographic and lifestyle factors in relation
to the presence and extent of chronic pain reported. 218,648
(43.7%) participants stated that they experienced chronic
pain in at least one site (head, hip, knee, shoulder, head,
abdomen or widespread) for 3 or more months. 115,193
(23.0%) reported one site of chronic pain, 81,406 (16.3%)
2–3 sites, 14,924 (3.0%) 4–7 sites, and 7125 (1.4%)
reported widespread pain. Participants with a greater num-
ber of chronic pain sites were more likely to be female,
have lower socioeconomic status, were current or previous
smokers, never drank alcohol or on special occasions only,
be obese, and participate in moderate amounts of physical
activity.
Individual LTCs, extent of multimorbidity and chronic
pain
150,481 participants (69.1%) who reported having chronic
pain also reported having one or more LTC, and 78,764
(36.2%) had two or more LTCs. Figure 1 shows each LTC
examined and the frequency of participants within that
LTC category reporting chronic pain (in at least one site).
Notably, chronic pain was highly prevalent in participants
with LTCs: in 31 of the 45 LTCs measured, half or more of
participants reported experiencing chronic pain. In partici-
pants with multimorbidity, 55.6% (N ¼ 76,376) also
reported chronic pain. Individually, the highest prevalence
of chronic pain appeared predominantly in people with
LTCs that are recognised as having pain as a predominant
symptom. Participants reporting migraine/headaches had
the largest frequency of chronic pain (74.8%, of which
91.6% reported chronic head pain), followed by chronic
fatigue syndrome (68.1%, of which 91.1% reported chronic
back pain), irritable bowel syndrome (67.4%, of which
90.0% reported chronic knee pain). However, chronic pain
was very common in other types of LTCs, including dis-
eases of the digestive system (diverticular disease (63.4%;
of which 91.8% reported chronic knee pain); dyspepsia
(60.7%; of which 92.2% reported chronic knee pain)) and
mental health based LTCs (depression (59.6%; of which
90.2% reported chronic knee pain), and alcohol problems
(58.6%; of which 95.4% reported chronic hip pain). Inter-
estingly, participants with some individual LTCs that are
known to have acute pain symptoms such as gout, reported
a lower frequency of chronic pain (46.6%).
We next measured the relationship between the extent of
chronic pain reported and type of LTC by examining the
number of sites of chronic pain reported by participants
with particular LTCs (Figure 2). Participants with chronic
fatigue syndrome had the highest prevalence of widespread
pain, with 17.6% reporting this. Widespread pain was also
commonly reported by participants with connective tissue
diseases (10.0%), multiple sclerosis (8.8%) and psychoac-
tive substance misuse (7.2%). Reporting of four to seven
sites of chronic pain were most prevalent in participants
with psychoactive substance misuse (12.4%) and chronic
fatigue syndrome (10.4%).
LTCs and risk of chronic pain
To investigate the relationship between the presence of
chronic pain and the extent of multimorbidity experienced,
we examined the relative risk ratio (RRR) of chronic pain
status across the LTC count categories using multinomial
logistic regression (Table 2). These models controlled for
age, sex, Townsend score, smoking status, alcohol intake,
BMI, and physical activity level. There was a dose-based
relationship observed between the presence of chronic pain
and LTC count: a 36% increased risk of chronic pain was
observed in those with a single LTC (RRR 1.36, confidence
intervals (CI) 1.34–1.38), an 88% increased risk for those
with two to three LTCs (RRR 1.88, CI 1.85–1.91) and more
than three times the risk for those with four or more LTCs
(RRR 3.56, CI 3.44–3.68) compared to those with no LTCs.
To further elucidate the relationship between LTC count
and chronic pain, we carried out a multinomial logistic
regression of LTC count and number of pain sites (extent
of chronic pain, shown in Table 3) controlling for demo-
graphic and lifestyle variables as described above. As with
chronic pain presence, there was a dose-based relationship
between multimorbidity count and number of sites of
chronic pain. This was most apparent in the widespread
pain group, where having a LTC count 4 increased the
risk of widespread pain by over 20 times (RRR 20.13, CI
18.26–22.19) compared with participants with no LTCs.
Discussion
Our study has shown that chronic pain is extremely com-
mon across a wide range of LTCs (N ¼ 45), with chronic


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1. Prevalence of chronic pain in participants with each of the included 45 long-term conditions. RA: rheumatoid arthritis; AS:
ankylosing spondylitis.
Figure 2. Number of chronic pain sites in each LTC. RA: rheumatoid arthritis; AS: ankylosing spondylitis.
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pain being reported in more than 50% of people with 31
different LTCs. Over half (53.4%) of participants with 2–3
LTCs and almost three quarters of those with 4 LTCs
(71.5%) reported at least one site of chronic pain, which
was twice and four times more likely than people with no
LTCs, respectively. When examining individual types of
LTCs co-occurring with chronic pain, we found that it was
highly prevalent in both physical LTCs, e.g. migraine, where
over 70% of participants reported chronic pain, and mental
health based LTCs such as depression and anxiety, which
showed over half of participants reporting chronic pain. The
relationship between chronic pain status, the number of
chronic pain sites and LTC count persisted when controlling
for the lifestyle and demographic factors of participants.
When examining the relationship with the extent of chronic
pain, there was a strong relationship between LTC count and
chronic pain; participants with 4 LTCs were around 16
times more likely to have chronic pain in between four and
seven sites, and 20 times as likely to have chronic wide-
spread pain throughout the body. Thus, there is strong evi-
dence for the relationship between both the presence and
extent of chronic pain and the number of LTCs experienced.
The results presented in this study expand on current
literature on the relationship between LTCs and chronic
pain. Previous research has shown that there is an associa-
tion between both physical and mental health based indi-
vidual LTCs and chronic pain. Our work concurs with
existing literature that shows that chronic pain is common
in people with LTCs that report pain as the primary symp-
tom (such as migraine, chronic fatigue and irritable bowel
syndrome), and mental health conditions. However, we
also show here that it is also commonly associated with
several digestive system related LTCs such as dyspepsia.
Previous studies have examined migraines and specific
sites of chronic pain, highlighting its co-occurrence with
specific sites of chronic pain, including low back pain.22
When examining mental health LTCs, we found one UK
Biobank study that examined chronic pain, major depres-
sion and bipolar disorder, it reported a strong relationship
between these conditions and both presence and extent of
chronic pain.14 A nationally representative sample of
patients experiencing mood and anxiety disorders found a
significant relationship between the presence of chronic
pain and mood and anxiety disorders, particularly panic
disorder and post-traumatic stress disorder.23 Further, one
study by Nicholl et al. described the positive relationship
between onset of chronic widespread pain and psychosocial
factors such as sleep problems, anxiety and depression.24
Previous research has highlighted the impact of chronic
pain in conditions where fatigue is a major symptom, par-
ticularly in patients diagnosed with fibromyalgia25,26 or
chronic fatigue syndrome.27,28
To date, no general population analyses exist showing
the relationship between the number of sites of chronic pain
and the degree of multimorbidity or the range of individual
LTCs presented here. We were able to find only a single
study that characterised the relationship between chronic
pain and multimorbidity. Scherer et al.18 presented results
from a study of 3189 chronic pain patients in primary care
aged 65 or older, showing that the level of chronic pain was
positively associated with presence of chronic gastritis,
hyperuricemia/gout, cardiac insufficiency, neuropathies
and depression. However, this paper only examined 8
LTCs, and represents results in an elderly population only.
We for the first time here highlight a strong association
between increasing number of LTCs and both the presence
and extent of chronic pain using a large number of LTCs
and in a population aged between 37 and 73 years old. Our
results show that chronic pain is an important factor for
consideration in the clinical management of patients with
specific LTCs and/or multimorbidity.
A clear strength of this study is the large size of the
cohort, UK Biobank provides data on over half a million
people with reports of a broad range of LTCs (N ¼ 45) and
chronic pain. In addition, details on a comprehensive list of
potential confounding variables (age, sex, socioeconomic
deprivation (as measured using the Townsend score),
smoking status, frequency of alcohol intake, BMI and phys-
ical activity) were present and adjusted for in our models.
There are some limitations to this study. LTCs were
based on self-report data as given by participants and may
be under or over-reported and we do not know about the
severity of each LTC. Further, we were restricted on how
chronic pain was assessed in UK Biobank; in particular on
Table 2. Multinomial logistic regression model showing relative risk of chronic pain sites in participants with 0, 1, 2–3 and4 long-term
conditions. All p-values were two sided and <0.01.
Outcome variable
Presence of chronic pain
(RRR (95% CI)
Model 1: adjusted for age, sex,
Townsend score (deprivation)
Presence of chronic pain
(RRR (95% CI)
Model 2: Model 1þ smoking, alcohol,
BMI and physical activity levels
Number of long-term conditions Have chronic pain
0 1 1
1 1.43 (1.43–1.45) 1.36 (1.34–1.38)
2–3 2.13 (2.10–2.16) 1.88 (1.85–1.91)
4 4.56 (4.41–4.71) 3.56 (3.44–3.68)
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the specific sites of pain, and we did not have information
about pain intensity or interference, which is a limitation.
While we had data on seven sites of pain as well as wide-
spread pain the use of a regional pain scale29 would have
allowed a more detailed examination of pain locations.
Further, our classification of ‘pain all over the body’ as
widespread pain, making it distinct from those with 4–7
sites of chronic pain, was based on an understanding that
participants who selected this option feel differently about
their pain than those who selected separate sites of pain;
this classification has been used previously.14,30 Chronic
pain is a condition in its own right31 and can be independent
of other LTCs experienced; however, it may be that partic-
ular LTCs are associated with the development of chronic
pain or vice versa, as is well researched for mood problems,
such as depression.32,33 In this cross-sectional study we
have no information on the temporal nature of chronic pain
and LTC development to investigate this issue further.
Finally, UK Biobank is a selected population, and is not
representative of the wider UK general population. Partici-
pants in UK Biobank are known to be mostly White British
and comparatively less socioeconomically deprived than
the UK average. This may mean that our estimates of the
prevalence of chronic pain in those with specific LTCs or
multimorbidity is likely to be conservative. However, this
work is important and is the first to highlight the prevalence
of pain in people living with multimorbidity.
The recently published NICE guidelines on multimor-
bidity highlight that healthcare providers should be alert
to the possibility of chronic pain in patients, and stresses a
need to examine whether the patients existing pain man-
agement is appropriate.34 The impact of chronic pain on
an individual’s quality of life35 and on society36 is well
established yet the impact of living with an additional
LTC or multimorbidity alongside chronic pain is less well
understood and explored. Our study suggests that chronic
pain is a key factor for consideration in the clinical man-
agement of patients with LTCs and multimorbidity. Fur-
ther research is required to explore the impacts, if any, on
health outcomes including the effect of chronic pain and
widespread pain on hospitalisations and mortality in peo-
ple with multimorbidity.
Conclusions
This study represents the first examination of the preva-
lence of chronic pain in participants with a broad range
of LTCs and differing levels of multimorbidity. We have
highlighted a much-neglected area, namely the co-
existence of chronic pain with multimorbidity and specific
LTCs, that demands both research and clinical consider-
ation. It is vital to understand the impact of chronic pain on
health-related outcomes in order to inform future manage-
ment of patients who experience chronic pain alongside
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